It's either Pfizer because it's main cancer drug is going off patent in a few years or someone who sees potential in a drug not targeting surface antigen markers which is old IP . Cell nucleus penetrative antibodies are the new potential in cancer treatment. Novel and unique we are.
- Forums
- ASX - By Stock
- Ann: New PAT-DX3 data demonstrates synthetic lethality
It's either Pfizer because it's main cancer drug is going off...
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.51M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 2842383 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 856022 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 2642383 | 0.008 |
17 | 4746715 | 0.007 |
11 | 2787680 | 0.006 |
8 | 3144992 | 0.005 |
5 | 4324000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 856022 | 2 |
0.010 | 1830082 | 5 |
0.011 | 1380000 | 4 |
0.012 | 372407 | 3 |
0.013 | 990000 | 2 |
Last trade - 08.48am 29/04/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable